Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-08-21 16:35:09 ET · period of report 2026-08-19 · accession 0001384243-26-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-21 16:35 | 2026-08-19 | KNSA | Quart Barry D | Dir | G - Gift | $0.00 | -2,600 | 12.7K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-08-19 | G | D | 2,600 | $0.00 | 12,745 | D | — | — | (F1) This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund. |